pneumococal pneumonia resistance to antibiotics

On the Investigation of Resistance Pattern of Pneumococcal Pneumonia toward Ceftriaxone, Azithromycin and Co-amoxiclav in Clinic and Laboratory

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014062318206N1

Enrollment

Registered

2014-10-03

Start date

2012-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumococcus pneumonia. Pneumonia due to Streptococcus pneumoniae

Interventions

Intervention 1: Azithromycin (orally 500 mg in first day, and 250 mg for the next days) for 10 days. Intervention 2: Amp Ceftriaxone (infusion 1 gram per 12 hours) for72 hours and then cap cefixim

Treatment - Drugs

Azithromycin (orally 500 mg in first day, and 250 mg for the next days) for 10 days

Amp Ceftriaxone (infusion 1 gram per 12 hours) for72 hours and then cap cefixime 200 mg one 12 hours for complete 10 days

Cap Co-amoxiclav (orally 625 mg per 8 hours) for 10 days

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age over 15 years old and diagnosis of pneumococcus infection. Exclusion criteria: epast antibiotc in 48 hours and toxicity drug reaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fever. Timepoint: 72 hours. Method of measurement: Thermometer.	—

Secondary

Measure	Time frame
Drug reaction. Timepoint: 48 hours. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzadeh Ebrahimzadeh

Birjand University of Medical Sciences

a.ebrahimzadeh@bums.ac.ir; mr14436@yahoo.comm.zare@live.co.uk+98 56 1444 8671

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026